Aspartate Aminotransferase to Platelet Index (APRI) as a Prognostic Factor for Overall Survival After TARE Y90 Resin Microspheres in Primary Liver Cancer Patients: Results from the European, Prospective Observational Study CIRT
Niklaus Schaefer, Dirk Arnold, Niels de Jong, Milan Geyer, Maria Urdaniz, Thomas Helmberger · 2026
Read Aspartate Aminotransferase to Platelet Index (APRI) as a Prognostic Factor for Overall Survival After TARE Y90 Resin Microspheres in Primary Liver Cancer Patients: Results from the European, Prospective Observational Study CIRT by Niklaus Schaefer, Dirk Arnold, Niels de Jong, Milan Geyer, Maria Urdaniz, Thomas Helmberger (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13642421.txt.
Description
Niklaus Schaefer led a 2026 analysis testing whether a simple liver blood index, APRI, predicts survival after yttrium-90 radioembolization for primary liver cancer. Patient selection for this arterial radiation treatment remains hard, since standard liver function scores do not fully capture hepatic reserve. The team drew on the prospective European CIRT study, analyzing 103 patients with bile duct cancer inside the liver and 377 with hepatocellular carcinoma, with cutoffs chosen from the data.
Higher APRI tracked with clearly shorter survival in both cancers, above 0.4 for cholangiocarcinoma and above 0.7 for hepatocellular carcinoma, and the links held after matching and other checks. The cutoffs separated survival under body-surface-area dosing but not under partition-model dosing. Doctors get a cheap, easy-to-use marker for outlook, with the caveat that tumor type and dosing method shape its value and further study is needed.
Catalog record
| CREATOR | Niklaus Schaefer, Dirk Arnold, Niels de Jong, Milan Geyer, Maria Urdaniz, Thomas Helmberger |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 22 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |